All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
- PMID: 35968870
- PMCID: PMC9377026
- DOI: 10.1093/infdis/jiac244
All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
Erratum in
-
Correction to: All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection.J Infect Dis. 2023 Apr 12;227(7):927. doi: 10.1093/infdis/jiac410. J Infect Dis. 2023. PMID: 36208283 Free PMC article. No abstract available.
Keywords: bronchiolitis; infants; lower respiratory tract infection; monoclonal antibody; pneumonia; respiratory syncytial virus.
Conflict of interest statement
Potential conflicts of interest. E. N. H. and C. B. N. are employees of Sanofi and may own Sanofi shares. M. W. was a contracted employee with Sanofi at the time the work was done and has no conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Similar articles
-
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556. N Engl J Med. 2020. PMID: 32726528 Clinical Trial.
-
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.Euro Surveill. 2024 Feb;29(6):2400046. doi: 10.2807/1560-7917.ES.2024.29.6.2400046. Euro Surveill. 2024. PMID: 38333937 Free PMC article.
-
[Respiratory tract infection and respiratory syncytial virus in young infants].Kansenshogaku Zasshi. 1995 Jan;69(1):68-72. doi: 10.11150/kansenshogakuzasshi1970.69.68. Kansenshogaku Zasshi. 1995. PMID: 7751737 Japanese.
-
Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?Curr Opin Infect Dis. 2015 Jun;28(3):221-4. doi: 10.1097/QCO.0000000000000161. Curr Opin Infect Dis. 2015. PMID: 25918956 Review.
-
[Respiratory syncytial virus: as an etiological agent of respiratory tract infection in children and adults].Przegl Epidemiol. 2008;62(4):767-75. Przegl Epidemiol. 2008. PMID: 19209739 Review. Polish.
Cited by
-
Quality of life burden on United States infants and caregivers due to lower respiratory tract infection and adjusting for selective testing: Pilot prospective observational study.Health Sci Rep. 2023 Jun 16;6(6):e1338. doi: 10.1002/hsr2.1338. eCollection 2023 Jun. Health Sci Rep. 2023. PMID: 37334041 Free PMC article.
-
Association of SNP-SNP interactions of surfactant protein genes with severity of respiratory syncytial virus infection in children.Physiol Genomics. 2024 Oct 1;56(10):691-697. doi: 10.1152/physiolgenomics.00045.2024. Epub 2024 Sep 2. Physiol Genomics. 2024. PMID: 39222066
References
-
- Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543–6. - PubMed
-
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143:127–32. - PubMed
-
- Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu Rev Virol 2020; 7:83–101. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical